Can persistent tumor necrosis factor release lead to refractory sarcoidosis?
Baughman
Robert P
RP
Interstitial Lung Disease and Sarcoidosis Clinic, University of Cincinnati Medical Center, OH 45267-0565, USA. Bob.Baughman@uc.edu
Lower
Elyse E
EE
D004351:Drug Resistance; D005938:Glucocorticoids / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D016676:Macrophages, Alveolar / Q000378:metabolism; D017565:Sarcoidosis, Pulmonary / Q000188:drug therapy / Q000503:physiopathology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*
D005938:Glucocorticoids; D014409:Tumor Necrosis Factor-alpha